NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

NEW YORK – With the US launch of its clinical-use digital pathology system, Epredia aims to win over labs with its high-throughput scanner, automated rescanning technology, and product menu that spans ...

NEW YORK – Digital pathology firm Gestalt said Wednesday that it has formed a partnership with dermatology medical technology firm Primaa to integrate that firm’s skin cancer test with Gestalt's ...

NEW YORK – Sera Prognostics said after the close of the market on Wednesday that its Q4 revenues fell 41 percent year over year. For the quarter ended Dec. 31, 2024, the Salt Lake City-based firm ...

Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...

The test can be used to better stratify cancer patients and determine the likelihood of breast cancer metastasizing.

NEW YORK – Cancer diagnostics firm AccuStem Sciences announced on Tuesday that it has acquired the license for the proprietary MicroRNA Signature Classifier (MSC) test for lung cancer screening from ...

NeoGenomics has promoted Chief Commercial Officer Warren Stone to president and chief operating officer (COO), effective April 1. Stone has over 25 years of general management and commercial ...

The company raised $57.5 million in February through a public offering, and the proceeds will be used to support commercial expansion in the US and EU.

The company also reported that its fourth quarter revenues dropped 7 percent from a year ago, while full-year 2024 revenues declined 3 percent.